PNPhichchapha Noikongdee

Phichchapha Noikongdee

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Phichchapha Noikongdee has a total of 4 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Evaluation of Classical and Modified Mixing Tests: Optimized Interpretation and a Structured Algorithm for Accurate Differentiation of the Causes of aPTT Prolongation

    by Pornnapa Police, Phichchapha Noikongdee, Tichayapa Phojanasenee, Dollapak Apipongrat

    Background: The activated partial thromboplastin time (aPTT) mixing test is widely used to investigate prolonged aPTT from factor deficiencies, inhibitors, or lupus anticoagulant (LA), but its interpretation remains challenging. Refining protocols and indices may improve accuracy. Objectives: To compare classical and modified aPTT mixing tests using conventional and novel indices for distinguishing FVIII deficiency, FVIII inhibitors, LA, and heparin, and to develop a structured interpretation algorithm. Methods: A total of 215 plasma samples (50 factor deficiencies, 51 FVIII inhibitors, 64 LA‐positive, 50 heparinized) underwent classical and modified 1:1 mixing tests. ICA and %Correction were calculated for immediate and 2‐h incubated mixes, while ΔICA and Δ%Correction were derived from their differences. Diagnostic performance was assessed by ROC analysis, and a proposed algorithm was designed. Results: Both protocols demonstrated excellent reliability (ICC > 0.90) and substantial agreement in interpretation ( κ = 0.65–0.75). The modified protocol consistently outperformed the classical approach, with index of circulating anticoagulant (ICA)‐based indices showing the greatest improvement. Novel indices ΔICA and Δ%Correction further enhanced diagnostic specificity compared with single indices. ΔICA achieved the highest performance, with near‐perfect accuracy in distinguishing factor deficiency from FVIII inhibitors and FVIII inhibitors from LA (AUC = 0.99 for both). The algorithm applying ΔICA after ICA of the immediate mix effectively separated factor deficiencies, FVIII inhibitors, and LA with high sensitivity and specificity, minimizing diagnostic overlap. Conclusions: The modified aPTT mixing test provides a reliable and practical approach for interpreting prolonged aPTT. The structured algorithm, combining the modified protocol with ΔICA, offers a systematic and clinically applicable framework for laboratory evaluation.


  • Analytical Validation of the High Concentrated Thrombin Time‐To‐Reptilase Time Ratio: A Proposed Assay for Monitoring Unfractionated Heparin in Patients With Low Fibrinogen Levels

    by Pornnapa Police, Phichchapha Noikongdee, Tichayapa Phojanasenee, Wittawat Chantkran, Dollapak Apipongrat

    Introduction: This study aimed to evaluate the analytical performance of the high‐concentrated thrombin time‐to‐reptilase time (hcTT/RT) ratio as a novel assay to neutralize fibrinogen effects and improve accuracy in unfractionated heparin (UFH) monitoring and to validate its use in clinical samples with low fibrinogen levels.Methods: A total of 240 heparin‐spiked plasma samples, prepared from 30 normal plasma samples with varying UFH concentrations, were analyzed. The hcTT/RT ratio's correlation with anti‐FXa activity and its sensitivity and specificity were compared with the hcTT assay. Additionally, 89 clinical samples from UFH‐treated patients with low fibrinogen levels were analyzed to validate the assay in clinical settings.Results: Both hcTT and the hcTT/RT ratio demonstrated strong correlations with anti‐FXa activity (R2 = 0.76 and 0.75, respectively). The hcTT/RT ratio outperformed hcTT in detecting subtherapeutic UFH levels, achieving higher diagnostic accuracy (AUC: 0.99 vs. 0.98, p < 0.001), greater sensitivity (89.2% vs. 86.7%), and perfect specificity (100.0% vs. 98.3%), with comparable performance for supratherapeutic UFH levels. Notably, the hcTT/RT ratio remained unaffected by low fibrinogen concentrations. In the validation study, the hcTT/RT ratio showed a stronger correlation with anti‐FXa activity than activated partial thromboplastin time and hcTT alone (R2 = 0.72 vs. 0.63 and 0.72 vs. 0.67, respectively) and had no significant correlation with fibrinogen levels (Spearman's r = −0.01).Conclusions: The hcTT/RT ratio is a reliable assay for monitoring UFH, especially in patients with low fibrinogen levels. Further large‐scale clinical studies are needed to evaluate its practical application in clinical settings.